https://shiratronics.com/news/ 2026-06-03T22:58:44+00:00 https://shiratronics.com/shiratronics-inc-completes-33m-million-series-a-financing/ 2022-09-30T18:28:44+00:00 https://shiratronics.com/shiratronics-inc-welcomes-new-ceo-robert-binney/ 2022-09-30T19:56:11+00:00 https://shiratronics.com/meet-the-winners-of-minne-innos-2021-blazer-awards/ 2022-09-30T19:57:17+00:00 https://shiratronics.com/70-best-minneapolis-medical-device-startups/ 2022-09-30T19:58:51+00:00 https://shiratronics.com/101-top-minnesota-medical-device-companies-and-startups-of-2021/ 2022-09-30T19:59:47+00:00 https://shiratronics.com/minne-innos-announces-2021-fire-awards/ 2022-09-30T20:01:16+00:00 https://shiratronics.com/dallas-invents-113-patents-granted-for-week-of-june-14/ 2022-09-30T20:05:55+00:00 https://shiratronics.com/shiratronics-inc-receives-fda-breakthrough-device-designation-for-chronic-migraine-neurostimulation/ 2023-04-06T21:07:40+00:00 https://shiratronics.com/shiratronics-begins-clinical-trials-raises-5m-for-chronic-migraine-relief/ 2023-09-27T15:41:23+00:00 https://shiratronics.com/shiratronics-announces-landmark-achievement-worlds-first-implant-of-its-innovative-chronic-migraine-system/ 2024-01-23T13:53:50+00:00 https://shiratronics.com/shiratronics-announces-groundbreaking-milestone-worlds-first-trial-phase-procedures-for-their-chronic-migraine-therapy-system-in-australian-pilot-study/ 2024-01-23T13:54:41+00:00 https://shiratronics.com/shiratronics-completes-australian-pilot-study-enrollment-prepares-for-pivotal-clinical-study/ 2024-02-13T00:35:51+00:00 https://shiratronics.com/shiratronics-unveils-data-on-their-neurostimulation-system-for-chronic-migraine/ 2024-07-16T19:55:57+00:00 https://shiratronics.com/shiratronics-raises-66-million-in-oversubscribed-series-b-financing-to-advance-pioneering-treatment-for-chronic-migraine/ 2024-10-09T16:01:13+00:00 https://shiratronics.com/shiratronics-initiates-ide-pivotal-study-of-implantable-neuromodulation-therapy-for-chronic-migraine/ 2024-12-03T15:34:02+00:00 https://shiratronics.com/medtech-strategist/ 2025-08-05T21:45:35+00:00 https://shiratronics.com/shiratronics-announces-positive-12-month-follow-up-results-from-reliev-cm-pilot-study-demonstrating-sustained-clinical-benefit-with-investigational-implantable-neuromodulation-therapy-for-chronic-mig/ 2026-06-03T22:17:07+00:00 https://shiratronics.com/shiratronics-completes-enrollment-in-reliev-cm2-pivotal-trial-of-implantable-extracranial-neuromodulation-systems-iens-for-chronic-migraine/ 2026-06-03T22:58:44+00:00